Dr. Stephanie Graff, MD, FACP is the Director of Breast Oncology at Lifespan Cancer Institute at the Legorreta Cancer Center at Brown University in Providence, Rhode Island. Dr. Graff serves as co-lead of the Breast Cancer Translational Research Disease Working Group at Brown University and is an Associate Professor of Medicine at the Warren-Alpert School of Medicine. Prior to joining the team at Lifespan/Brown in 2021, she was Director of both the Breast Program and Clinical Research at the Sarah Cannon Cancer Institute at HCA Midwest, as well as Associate Director of the Breast Cancer Research Program at Sarah Cannon Research Institute and National Breast Lead for the Sarah Cannon Cancer Network’s clinical programs. In addition, Dr. Graff serves as a medical advisor to the Dr. Susan Love Foundation for Breast Cancer Research.
Dr. Graff is board certified in Medical Oncology, Hematology, and Internal Medicine; and completed a breast oncology sub-fellowship at the University of Kansas. Dr. Graff has broad experience as a Principal Investigator on numerous clinical trials across all phases of drug development, in addition to work in translational research, genomics, and gender bias. In addition to scientific publications, she is an award-winning writer, social media influencer, and sought-after public speaker. She serves editorial roles at Cancer Medicine, Journal of Clinical Oncology, American Journal of Clinical Oncology, and Oncology Times. Dr. Graff has received the Frist Humanitarian Award for her work in the community, Healio® Disruptive Innovator Woman Disruptor of Year in 2022, and the RI American College of Physicians’ Benjamin L. Sapers Memorial Award for her “passion for pedagogy, academic rigor, empathy and humanism.” Ultimately, Dr. Graff is passionate about connecting with her patients to provide personalized, comprehensive oncology care, advancing breast cancer research, and breast cancer prevention.
Language here and here and here and.
Language here and here and here and here and here and here and here and. Language here and here and here and here and here and here and here and.